Development of effective therapeutics targeting the GABAA receptor: naturally occurring alternatives.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current pharmaceutical design

• Publication date

  2004-03-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/1381612043452767PMID 15078131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of flavones from the roots of Scutellaria baicalensis with the benzodiazepine site.

  2009cited by this paper
• Effect of l-tetrahydropalmatine on dopamine release and metabolism in the rat striatum

  2004cited by this paper
• A water lick conflict paradigm using drug experienced rats

  2004cited by this paper
• Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects

  2004cited by this paper
• Pharmacology of the benzodiazepine receptor

  2004cited by this paper
• Acute Hepatitis Induced by Kava Kava

  2003cited by this paper
• The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines.

  2003cited by this paper
• The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic.

  2003cited by this paper
• Songorine, a diterpenoid alkaloid of the genus Aconitum, is a novel GABA(A) receptor antagonist in rat brain.

  2003cited by this paper
• Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA(A) receptor.

  2002cited by this paper
• Structure-Activity Relationships of Flavonoids, Isolated from Scutellaria baicalensis, Binding to Benzodiazepine Site of GABAA Receptor Complex

  2002cited by this paper
• Selective actions on sleep or anxiety by exploiting GABA-A/benzodiazepine receptor subtypes.

  2002cited by this paper
• 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels.

  2002cited by this paper
• A new benzodiazepine pharmacology.

  2002cited by this paper
• Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal.

  2002cited by this paper
• The Social Organisation of a Population of Sumatran Orang-Utans

  2002cited by this paper
• Two flavones from Scutellaria baicalensis Georgi and their binding affinities to the benzodiazepine site of the GABAA receptor complex.

  2002cited by this paper
• Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi.

  2002cited by this paper
• A review of molecular modeling approaches to pharmacophore models and structure-activity relationships of ion channel modulators in CNS.

  2002cited by this paper
• Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.

  2002cited by this paper
• The experimental pharmacotherapy of benzodiazepine withdrawal.

  2002cited by this paper
• SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.

  2001cited by this paper
• Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABA(A) receptor complex.

  2001cited by this paper
• Interactions between dopamine D1 receptors and γ-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies

  2001cited by this paper
• Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors

  2001cited by this paper
• GABA(A) receptor subtypes: dissecting their pharmacological functions.

  2001cited by this paper
• Glomerular hypertension--an under-appreciated aspect of chronic rejection.

  2001cited by this paper
• 3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors.

  2001cited by this paper
• DL-Tetrahydropalmatine may act through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats.

  2001cited by this paper
• Molecular and neuronal substrate for the selective attenuation of anxiety.

  2000cited by this paper
• Advances in flavonoid research since 1992.

  2000cited by this paper
• GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.

  2000cited by this paper
• Mechanism of action of the hypnotic zolpidem in vivo

  2000cited by this paper
• Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.

  2000cited by this paper
• Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

  2000cited by this paper
• The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats.

  1999cited by this paper
• Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands.

  1999cited by this paper
• Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

  1999cited by this paper
• Effects of Valeriana Officinalis Extracts on [3H]Flunitrazepam Binding, Synaptosomal [3H]GABA Uptake, and Hippocampal [3H]GABA Release

  1999cited by this paper
• Flavonoids and the Central Nervous System: from Forgotten Factors to Potent Anxiolytic Compounds

  1999cited by this paper
• An update on GABAA receptors.

  1999cited by this paper
• GABAB receptors - the first 7TM heterodimers.

  1999cited by this paper
• Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex.

  1999cited by this paper
• Pharmacological characterization of 6-bromo-3'-nitroflavone, a synthetic flavonoid with high affinity for the benzodiazepine receptors.

  1998cited by this paper
• Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits.

  1998cited by this paper
• Neuroactive flavonoids: new ligands for the Benzodiazepine receptors.

  1998cited by this paper
• A Risk-Benefit Assessment of Flumazenil in the Management of Benzodiazepine Overdose

  1997cited by this paper
• Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors.

  1997cited by this paper
• Overview—Flavonoids: A New Family of Benzodiazepine Receptor Ligands

  1997cited by this paper
• Enhancement by flumazenil of dopamine release in the nucleus accumbens of rats repeatedly exposed to diazepam or imidazenil

  1997cited by this paper
• GABAA receptor pharmacology.

  1996cited by this paper
• Cirsiliol and caffeic acid ethyl ester, isolated from Salvia guaranitica, are competitive ligands for the central benzodiazepine receptors.

  1996cited by this paper
• Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients.

  1996cited by this paper
• Benzodiazepines on trial: a research strategy for their rehabilitation.

  1996cited by this paper
• A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer

  1996cited by this paper
• Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.

  1995cited by this paper
• The GABAA receptors.

  1995cited by this paper
• Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects.

  1995cited by this paper
• Biological function of GABAA/benzodiazepine receptor heterogeneity.

  1995cited by this paper
• GABAA receptor agonists, partial agonists, and antagonists. Design and therapeutic prospects.

  1994cited by this paper
• Basal forebrain injections of the benzodiazepine partial inverse agonist FG 7142 enhance memory of rats in the double Y-maze.

  1994cited by this paper
• Free radical scavenging and antioxidant activity of plant flavonoids.

  1994cited by this paper
• Regulation of gamma-aminobutyric acid synthesis in the brain.

  1993cited by this paper
• Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.

  1993cited by this paper
• Clinical Uses of Benzodiazepines

  1993cited by this paper
• GABAA-receptors: drug binding profile and distribution of receptors containing the alpha 2-subunit in situ.

  1993cited by this paper
• Benzodiazepines: use, abuse, and consequences.

  1992cited by this paper
• GABAA receptors: ligand-gated Cl- ion channels modulated by multiple drug-binding sites.

  1992cited by this paper
• A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.

  1992cited by this paper
• Development of natural products as drugs acting on central nervous system.

  1991cited by this paper
• Generation of Two Forms of the γ‐Aminobutyric AcidA Receptor γ‐2‐Subunit in Mice by Alternative Splicing

  1991cited by this paper
• Novel anxiolytics that act as partial agonists at benzodiazepine receptors.

  1990cited by this paper
• GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.

  1990cited by this paper
• Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site.

  1990cited by this paper
• Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties.

  1990cited by this paper
• Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.

  1989cited by this paper
• Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents.

  1989cited by this paper
• Electrophysiology of benzodiazepine receptor ligands: multiple mechanisms and sites of action.

  1988cited by this paper
• Patch-clamp study of gamma-aminobutyric acid receptor Cl- channels in cultured astrocytes.

  1988cited by this paper
• High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro.

  1988cited by this paper
• Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore.

  1988cited by this paper
• Ro 16-6028: A Novel Anxiolytic Acting as a Partial Agonist at the Benzodiazepine Receptor

  1988cited by this paper
• Barbiturate and benzodiazepine modulation of GABA receptor binding and function.

  1986cited by this paper
• Modulation of ligands binding to the benzodiazepine receptor by an endogenous inhibitor (GABA-modulin) and bicuculline.

  1986cited by this paper
• The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard

  1985cited by this paper
• Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

  1985cited by this paper
• A gamma-aminobutyric acid/benzodiazepine receptor complex from bovine cerebral cortex. Improved purification with preservation of regulatory sites and their interactions.

  1984cited by this paper
• Isolation and identification of "diazepam-like" compounds from bovine urine.

  1983cited by this paper
• GABA‐Benzodiazepine‐Barbiturate Receptor Interactions

  1981cited by this paper
• Diazepam and (--)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons.

  1981cited by this paper
• The reliability of the hole-board apparatus

  1975cited by this paper
• Validity of head-dipping as a measure of exploration in a modified hole-board

  1975cited by this paper
• Evaluation of Bicuculline as a GABA Antagonist

  1971cited by this paper
• Localizing 3H-GABA in Nerve Terminals of Rat Cerebral Cortex by Electron Microscopic Autoradiography

  1971cited by this paper

• Anesthetics and analgesic activities of herbal medicine: Review of the possible mechanism of action

  2022cites this paper
• Neuropharmacological effects of d-pinitol and its possible mechanisms of action.

  2019cites this paper
• Structure-Dependent Activity of Natural GABA(A) Receptor Modulators

  2018influential citation
• The effect of hydro -alchoholic exteract of ( Matricaria recutita L.) on pentylenetetrazole-induced seizure and its relationship with nitric oxide in mice

  2018cites this paper
• Anesthetic Agents of Plant Origin: A Review of Phytochemicals with Anesthetic Activity

  2017cites this paper
• HPLC-Based Activity Profiling for GABAA Receptor Modulators in Extracts: Validation of an Approach Utilizing a Larval Zebrafish Locomotor Assay.

  2017cites this paper
• Neuroprotective effects of gabaergic phenols correlated with their pharmacological and antioxidant properties

  2017cites this paper
• Hispidulin alleviated methamphetamine-induced hyperlocomotion by acting at α6 subunit-containing GABAA receptors in the cerebellum

  2016cites this paper
• Rhodiola Rosea L.- An Evaluation of Safety and Efficacy in the Context of a Neurological Disorder, Alzheimer Disease

  2015cites this paper
• Involvement of the GABAergic system in the neuroprotective and sedative effects of acacetin 7-O-glucoside in rodents

  2015cites this paper
• GABA Receptors: Pharmacological Potential and Pitfalls.

  2015cites this paper
• Souroubea sympetala (Marcgraviaceae): a medicinal plant that exerts anxiolysis through interaction with the GABAA benzodiazepine receptor.

  2014cites this paper
• Effect of green tea catechins on PTZ-induced seizure in male mice

  2013cites this paper
• Characterization of the Anxiolytic Activity of Nunavik Rhodiola rosea

  2013cites this paper
• HPLC-based Activity Profiling – Discovery of Sanggenons as GABAA Receptor Modulators in the Traditional Chinese Drug Sang bai pi (Morus alba Root Bark)

  2012cites this paper
• Neuroprotective Effects of Vitexin, a Flavonoid, on Pentylenetetrazole‐Induced Seizure in Rats

  2012cites this paper
• HPLC-based activity profiling for GABAA receptor modulators from the traditional Chinese herbal drug Kushen (Sophora flavescens root)

  2011cites this paper
• Synthesis, hypnotic properties and molecular modeling studies of 1,2,7,9-tetraaza-spiro[4.5]dec-2-ene-6,8,10-triones.

  2011cites this paper
• Anxiety-Reducing Tropical Plants: Phytochemical and Pharmacological Characterization of Souroubea sympetala and Piper amalago

  2011cites this paper
• The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats.

  2010cites this paper
• HPLC-based activity profiling: discovery of piperine as a positive GABA(A) receptor modulator targeting a benzodiazepine-independent binding site.

  2010cites this paper
• HPLC-based activity profiling approach for the discovery of GABAA receptor ligands using an automated two microelectrode voltage clamp assay on Xenopus oocytes.

  2008cites this paper
• Comparative anticancer effects of flavonoids and diazepam in cultured cancer cells.

  2008cites this paper
• HPLC-Based Activity Profiling Approach for the Discovery of GABAA Receptor Ligands using an Automated Two Microelectrode Voltage Clamp Assay on Xenopus Oocytes

  2008cites this paper
• Possible role of GABAA-benzodiazepine receptor in anticonvulsant effects of Pasipay in rats.

  2008cites this paper
• Anticonvulsive effects of intracerebroventricular administration of rutin in rats.

  2008cites this paper
• NEURONAL HYPOTHALAMIC PLASTICITY IN CHICKEN: A DEVELOPMENTAL AND PHARMACOLOGICAL PERSPECTIVE

  2007cites this paper
• Radiosynthesis and biological evaluation of an 18F-labeled derivative of the novel pyrazolopyrimidine sedative-hypnotic agent indiplon.

  2007cites this paper
• Reduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1

  2007cites this paper
• Hypersensitivity reactions to complementary and alternative medicine products.

  2006cites this paper
• Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha.

  2006cites this paper
• Stimulating effects of H1-antagonists.

  2006cites this paper
• Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders.

  2005cites this paper
• GABA(A) receptor channel pharmacology.

  2005cites this paper
• Chapter 4 – Synthesis of selected biologically active compounds via allylboration

  2005cites this paper
• Synthesis of 4-aryl-2-pyrrolidones and beta-aryl-gamma-amino-butyric acid (GABA) analogues by Heck arylation of 3-pyrrolines with arenediazonium tetrafluoroborates. Synthesis of (+/-)-rolipram on a multigram scale and chromatographic resolution by semipreparative chiral simulated moving bed chromato

  2005cites this paper
• Quinazolines revisited: search for novel anxiolytic and GABAergic agents.

  2005cites this paper
• Propofol: therapeutic indications and side-effects.

  2004cites this paper